Clinical and Translational Medicine (Apr 2022)
Deciphering the quality of SARS‐CoV‐2 specific T‐cell response associated with disease severity, immune memory and heterologous response
- Alberto Pérez‐Gómez,
- Carmen Gasca‐Capote,
- Joana Vitallé,
- Francisco J. Ostos,
- Ana Serna‐Gallego,
- María Trujillo‐Rodríguez,
- Esperanza Muñoz‐Muela,
- Teresa Giráldez‐Pérez,
- Julia Praena‐Segovia,
- María D. Navarro‐Amuedo,
- María Paniagua‐García,
- Manuel García‐Gutiérrez,
- Manuela Aguilar‐Guisado,
- Inmaculada Rivas‐Jeremías,
- María Reyes Jiménez‐León,
- Sara Bachiller,
- Alberto Fernández‐Villar,
- Alexandre Pérez‐González,
- Alicia Gutiérrez‐Valencia,
- Mohammed Rafii‐El‐Idrissi Benhnia,
- Daniela Weiskopf,
- Alessandro Sette,
- Luis F. López‐Cortés,
- Eva Poveda,
- Ezequiel Ruiz‐Mateos,
- Virgen del Rocío Hospital COVID‐19 and COHVID‐GS Working Teams
Affiliations
- Alberto Pérez‐Gómez
- Clinical Unit of Infectious Diseases Microbiology and Preventive Medicine Institute of Biomedicine of Seville (IBiS) Virgen del Rocío University Hospital CSIC University of Seville Seville Spain
- Carmen Gasca‐Capote
- Clinical Unit of Infectious Diseases Microbiology and Preventive Medicine Institute of Biomedicine of Seville (IBiS) Virgen del Rocío University Hospital CSIC University of Seville Seville Spain
- Joana Vitallé
- Clinical Unit of Infectious Diseases Microbiology and Preventive Medicine Institute of Biomedicine of Seville (IBiS) Virgen del Rocío University Hospital CSIC University of Seville Seville Spain
- Francisco J. Ostos
- Clinical Unit of Infectious Diseases Microbiology and Preventive Medicine Institute of Biomedicine of Seville (IBiS) Virgen del Rocío University Hospital CSIC University of Seville Seville Spain
- Ana Serna‐Gallego
- Clinical Unit of Infectious Diseases Microbiology and Preventive Medicine Institute of Biomedicine of Seville (IBiS) Virgen del Rocío University Hospital CSIC University of Seville Seville Spain
- María Trujillo‐Rodríguez
- Clinical Unit of Infectious Diseases Microbiology and Preventive Medicine Institute of Biomedicine of Seville (IBiS) Virgen del Rocío University Hospital CSIC University of Seville Seville Spain
- Esperanza Muñoz‐Muela
- Clinical Unit of Infectious Diseases Microbiology and Preventive Medicine Institute of Biomedicine of Seville (IBiS) Virgen del Rocío University Hospital CSIC University of Seville Seville Spain
- Teresa Giráldez‐Pérez
- Clinical Unit of Infectious Diseases Microbiology and Preventive Medicine Institute of Biomedicine of Seville (IBiS) Virgen del Rocío University Hospital CSIC University of Seville Seville Spain
- Julia Praena‐Segovia
- Clinical Unit of Infectious Diseases Microbiology and Preventive Medicine Institute of Biomedicine of Seville (IBiS) Virgen del Rocío University Hospital CSIC University of Seville Seville Spain
- María D. Navarro‐Amuedo
- Clinical Unit of Infectious Diseases Microbiology and Preventive Medicine Institute of Biomedicine of Seville (IBiS) Virgen del Rocío University Hospital CSIC University of Seville Seville Spain
- María Paniagua‐García
- Clinical Unit of Infectious Diseases Microbiology and Preventive Medicine Institute of Biomedicine of Seville (IBiS) Virgen del Rocío University Hospital CSIC University of Seville Seville Spain
- Manuel García‐Gutiérrez
- Clinical Unit of Infectious Diseases Microbiology and Preventive Medicine Institute of Biomedicine of Seville (IBiS) Virgen del Rocío University Hospital CSIC University of Seville Seville Spain
- Manuela Aguilar‐Guisado
- Clinical Unit of Infectious Diseases Microbiology and Preventive Medicine Institute of Biomedicine of Seville (IBiS) Virgen del Rocío University Hospital CSIC University of Seville Seville Spain
- Inmaculada Rivas‐Jeremías
- Clinical Unit of Infectious Diseases Microbiology and Preventive Medicine Institute of Biomedicine of Seville (IBiS) Virgen del Rocío University Hospital CSIC University of Seville Seville Spain
- María Reyes Jiménez‐León
- Clinical Unit of Infectious Diseases Microbiology and Preventive Medicine Institute of Biomedicine of Seville (IBiS) Virgen del Rocío University Hospital CSIC University of Seville Seville Spain
- Sara Bachiller
- Clinical Unit of Infectious Diseases Microbiology and Preventive Medicine Institute of Biomedicine of Seville (IBiS) Virgen del Rocío University Hospital CSIC University of Seville Seville Spain
- Alberto Fernández‐Villar
- Pneumology Service Galicia Sur Health Research Instituto (IIS Galicia Sur) Complexo Hospitalario Universitario de Vigo SERGAS‐UVigo Vigo Spain
- Alexandre Pérez‐González
- Group of Virology and Pathogenesis Galicia Sur Health Research Institute (IIS Galicia Sur) Complexo Hospitalario Universitario de Vigo SERGAS‐UVigo Vigo Spain
- Alicia Gutiérrez‐Valencia
- Clinical Unit of Infectious Diseases Microbiology and Preventive Medicine Institute of Biomedicine of Seville (IBiS) Virgen del Rocío University Hospital CSIC University of Seville Seville Spain
- Mohammed Rafii‐El‐Idrissi Benhnia
- Clinical Unit of Infectious Diseases Microbiology and Preventive Medicine Institute of Biomedicine of Seville (IBiS) Virgen del Rocío University Hospital CSIC University of Seville Seville Spain
- Daniela Weiskopf
- Center for Infectious Disease and Vaccine Research La Jolla Institute for Immunology (LJI) La Jolla California USA
- Alessandro Sette
- Center for Infectious Disease and Vaccine Research La Jolla Institute for Immunology (LJI) La Jolla California USA
- Luis F. López‐Cortés
- Clinical Unit of Infectious Diseases Microbiology and Preventive Medicine Institute of Biomedicine of Seville (IBiS) Virgen del Rocío University Hospital CSIC University of Seville Seville Spain
- Eva Poveda
- Group of Virology and Pathogenesis Galicia Sur Health Research Institute (IIS Galicia Sur) Complexo Hospitalario Universitario de Vigo SERGAS‐UVigo Vigo Spain
- Ezequiel Ruiz‐Mateos
- Clinical Unit of Infectious Diseases Microbiology and Preventive Medicine Institute of Biomedicine of Seville (IBiS) Virgen del Rocío University Hospital CSIC University of Seville Seville Spain
- Virgen del Rocío Hospital COVID‐19 and COHVID‐GS Working Teams
- Clinical Unit of Infectious Diseases Microbiology and Preventive Medicine Institute of Biomedicine of Seville (IBiS) Virgen del Rocío University Hospital CSIC University of Seville Seville Spain
- DOI
- https://doi.org/10.1002/ctm2.802
- Journal volume & issue
-
Vol. 12,
no. 4
pp. n/a – n/a
Abstract
Abstract SARS‐CoV‐2 specific T‐cell response has been associated with disease severity, immune memory and heterologous response to endemic coronaviruses. However, an integrative approach combining a comprehensive analysis of the quality of SARS‐CoV‐2 specific T‐cell response with antibody levels in these three scenarios is needed. In the present study, we found that, in acute infection, while mild disease was associated with high T‐cell polyfunctionality biased to IL‐2 production and inversely correlated with anti‐S IgG levels, combinations only including IFN‐γ with the absence of perforin production predominated in severe disease. Seven months after infection, both non‐hospitalised and previously hospitalised patients presented robust anti‐S IgG levels and SARS‐CoV‐2 specific T‐cell response. In addition, only previously hospitalised patients showed a T‐cell exhaustion profile. Finally, combinations including IL‐2 in response to S protein of endemic coronaviruses were the ones associated with SARS‐CoV‐2 S‐specific T‐cell response in pre‐COVID‐19 healthy donors’ samples. These results could have implications for protective immunity against SARS‐CoV‐2 and recurrent COVID‐19 and may help for the design of new prototypes and boosting vaccine strategies.
Keywords